Marker Therapeutics Inc
NASDAQ:MRKR
Marker Therapeutics Inc Stock, NASDAQ:MRKR
4551 Kennedy Commerce Drive, Suite 2240, Houston, Texas 77032
United States of America
Phone: +1.713.400.6400
Number of Employees: 67
Description
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.